Key Points
- Bonk director Mitchell Austin Rudy bought 12,000 shares on June 10 at an average price of $1.37, spending $16,440 and increasing his direct holdings by 23.37% to 63,341 shares.
- The company’s stock was trading down 2.2% at $1.33, near its 1-year low of $1.25 and far below its 1-year high of $46.90, with a market cap of about $10.64 million.
- Analysts remain cautious on BNKK, with the consensus rating at Sell despite one recent upgrade to Hold; the company also reported a quarterly loss of $0.23 per share on revenue of $0.79 million.
Bonk, Inc. (NASDAQ:BNKK - Get Free Report) Director Mitchell Austin Rudy purchased 12,000 shares of the company's stock in a transaction that occurred on Wednesday, June 10th. The shares were acquired at an average price of $1.37 per share, for a total transaction of $16,440.00. Following the completion of the purchase, the director directly owned 63,341 shares in the company, valued at $86,777.17. This represents a 23.37% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Mitchell Austin Rudy also recently made the following trade(s):
- On Thursday, April 9th, Mitchell Austin Rudy purchased 31,055 shares of Bonk stock. The stock was purchased at an average cost of $2.82 per share, for a total transaction of $87,575.10.
Bonk Trading Down 2.2%
BNKK stock opened at $1.33 on Wednesday. The company's 50 day moving average is $2.21 and its 200 day moving average is $3.18. The stock has a market cap of $10.64 million, a price-to-earnings ratio of -0.29 and a beta of 1.85. Bonk, Inc. has a 1-year low of $1.25 and a 1-year high of $46.90.
Bonk (NASDAQ:BNKK - Get Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) earnings per share (EPS) for the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.The company had revenue of $0.79 million for the quarter.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. Wall Street Zen upgraded Bonk from a "sell" rating to a "hold" rating in a report on Saturday. Weiss Ratings downgraded shares of Bonk from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of "Sell".
Read Our Latest Stock Analysis on BNKK
Institutional Trading of Bonk
A number of hedge funds and other institutional investors have recently modified their holdings of BNKK. State Street Corp purchased a new position in Bonk during the 4th quarter valued at about $33,000. Steward Partners Investment Advisory LLC bought a new position in shares of Bonk during the fourth quarter valued at approximately $37,000. Jane Street Group LLC purchased a new position in shares of Bonk during the fourth quarter valued at approximately $96,000. Finally, Geode Capital Management LLC bought a new stake in shares of Bonk in the 4th quarter worth approximately $128,000. 12.55% of the stock is owned by hedge funds and other institutional investors.
About Bonk
(
Get Free Report)
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
